Key result
Dihydropyridine calcium antagonists inhibit stimulus-dependent calcium entry into arterial cells, with their potency highly dependent on resting membrane potential and depolarizing stimulus duration.
Answers are grounded in this paper and cite their sources.
The pharmacological potency of dihydropyridine calcium antagonists in arterial cells is modulated by resting membrane potential and depolarizing stimulus duration.
This paper is a review of the experimental evidence showing that specific binding sites for dihydropyridine Ca antagonists are involved in inhibition of stimulus-dependent Ca entry into arterial cells and thereby in inhibition of the contractile response. The apparent affinity of the dihydropyridine binding site is related to the proportion of a high- and a low-affinity state which is regulated by membrane potential but could also be dependent upon other factors such as G proteins. Among Ca antagonists, a subgroup of agents exhibiting voltage dependence may be identified. Their apparent pharmacological potency is highly dependent on resting membrane potential and on the duration of the depolarizing stimulus.
No takes yet. Share an insight, caveat, or question.
Godfraind et al. (2008) reported a review. Calcium antagonists (dihydropyridines) was evaluated. Dihydropyridine calcium antagonists inhibit stimulus-dependent calcium entry into arterial cells, with their potency highly dependent on resting membrane potential and depolarizing stimulus duration.
Synapse has enriched 10 related papers. Consider them for comparative context: